Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2021-04-07 2021-04-05
Drug Identification Number 02378612 02378612
Brand name XARELTO XARELTO
Common or Proper name rivaroxaban tablets rivaroxaban tablets
Company Name BAYER INC BAYER INC
Ingredients RIVAROXABAN RIVAROXABAN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 90's 90's
ATC code B01AF B01AF
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-04-09 2021-04-09
Actual start date
Estimated end date 2021-04-12 2021-04-12
Actual end date 2021-04-07
Shortage status Avoided shortage Anticipated shortage
Company comments
Health Canada comments